Low plasma uric acid level in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Movement Disorders

• Publication date

  2007-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.21502PMID 17443703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.

  2006cited by this paper
• Weight loss in Parkinson’s disease

  2006cited by this paper
• Special low‐protein foods ameliorate postprandial off in patients with advanced Parkinson's disease

  2006cited by this paper
• Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey.

  2005cited by this paper
• Consumption of milk and calcium in midlife and the future risk of Parkinson disease

  2005cited by this paper
• Serum uric acid levels and the risk of Parkinson disease

  2005cited by this paper
• The association between serum ferritin and uric acid in humans

  2005cited by this paper
• Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002.

  2004cited by this paper
• Does cellular iron dysregulation play a causative role in Parkinson's disease?

  2004cited by this paper
• Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes

  2003cited by this paper
• Dopamine and Uric Acid Act as Antioxidants in the Repair of DNA Radicals: Implications in Parkinson's Disease

  2003cited by this paper
• Weight loss in Parkinson's disease

  2003cited by this paper
• Antioxidant and prooxidant properties of caffeine, theobromine and xanthine.

  2003cited by this paper
• Iron regulates xanthine oxidase activity in the lung.

  2002cited by this paper
• Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis.

  2002cited by this paper
• Comparison of uric acid and ascorbic acid in protection against EAE.

  2002cited by this paper
• The role of uric acid in protection against peroxynitrite-mediated pathology.

  2001cited by this paper
• Association of coffee and caffeine intake with the risk of Parkinson disease.

  2000cited by this paper
• Accuracy of diagnosis in patients with presumed Parkinson's disease.

  1999cited by this paper
• Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study

  1998cited by this paper
• Iron metabolism and Parkinson's disease.

  1998cited by this paper
• Free-living Daily Energy Expenditure in Patients with Parkinson's Disease

  1997cited by this paper
• Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.

  1996cited by this paper
• No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

  1995cited by this paper
• Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation.

  1994cited by this paper
• Complex I, Iron, and ferritin in Parkinson's disease substantia nigra

  1994cited by this paper
• A study of the nutritional status of elderly patients with Parkinson's disease.

  1994cited by this paper
• Iron(III) chloride injection increases nigral uric acid in guinea-pig.

  1993cited by this paper
• Iron(III) chloride injection increases nigral uric acid in guinea-pig

  1993cited by this paper
• Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment

  1992cited by this paper
• Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.

  1986cited by this paper
• Effect of L-dopa on renal handling of uric acid.

  1982cited by this paper

• Activity-tunable bimetallic iron-cobalt nanoflowers integrated with smartphones for rapid detection of human uric acid.

  2026cites this paper
• Enrichment of gut-derived metabolites in a Parkinson’s disease subtype with REM sleep behavior disorder

  2025cites this paper
• Machine learning-based non-invasive Parkinson’s disease diagnostic model using clinical blood biomarkers

  2025cites this paper
• The role of uric acid in Parkinson’s disease: a UK brain bank pathology-validated case–control study

  2025cites this paper
• Significance and amplification methods of the purine salvage pathway in human brain cells

  2024cites this paper
• No causal relationship between serum urate and neurodegenerative diseases: A Mendelian randomization study.

  2024cites this paper
• Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease

  2024cites this paper
• Elevated Serum Xanthine Oxidase and Its Correlation with Antioxidant Status in Patients with Parkinson’s Disease

  2024cites this paper
• Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis

  2024cites this paper
• Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study

  2023cites this paper
• Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies.

  2023cites this paper
• Longitudinal follow-up study of the association with gout and Alzheimer’s disease and Parkinson’s disease in Korea

  2023cites this paper
• Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Associations between blood essential metal mixture and serum uric acid: a cross-sectional study

  2023cites this paper
• Serum uric acid and Parkinson's disease: A systematic review and meta‐analysis

  2023cites this paper
• The Role of Uric Acid as an Antioxidant in Selected Neurodegenerative Disease Pathogenesis

  2022cites this paper
• Uric Acid in Parkinson′s Disease: What Is the Connection?

  2022cites this paper
• Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease

  2022cites this paper
• Serum Uric Acid Levels in Parkinson’s Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania

  2022cites this paper
• state of uric acid in Iraqi patients with Parkinson disease

  2022cites this paper
• Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease

  2021cites this paper
• Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson's disease: Longitudinal data from the PPMI study.

  2021cites this paper
• Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

  2021cites this paper
• A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease

  2021cites this paper
• Evidence-Based Discriminant Analysis: A New Insight into Iron Profile for the Diagnosis of Parkinson's Disease

  2021cites this paper
• Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI Study

  2021cites this paper
• Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease

  2021cites this paper
• Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.

  2021cites this paper
• SERUM URIC ACID LEVEL IS AN IMPORTANT PROGNOSTIC MARKER IN NEURODEGENERATIVE DISEASES

  2020cites this paper
• Risk of Parkinson’s disease following gout: a population-based retrospective cohort study in Taiwan

  2020cites this paper
• Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders

  2020cites this paper
• Biological fluid levels of iron and iron‐related proteins in Parkinson’s disease: Review and meta‐analysis

  2020cites this paper
• Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson’s Disease: Data from the PPMI Study

  2020cites this paper
• Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson’s Disease: A Case-Control Study

  2020influential citation
• Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: a systematic review.

  2020cites this paper
• Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways.

  2019cites this paper
• Feeding-produced subchronic high plasma levels of uric acid improve behavioral dysfunction in 6-hydroxydopamine-induced mouse model of Parkinson’s disease

  2019cites this paper
• Selenium and Other Trace Elements in the Etiology of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies

  2019cites this paper
• Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.

  2018cites this paper
• Biomarkers in Parkinson disease: studies on clinical, radiological and biological biomarkers

  2018cites this paper
• Genetic variants related to urate and risk of Parkinson's disease.

  2018cites this paper
• Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model

  2018cites this paper
• Association between serum uric acid level and multiple system atrophy: A meta-analysis.

  2018cites this paper
• Physiological functions and pathogenic potential of uric acid: A review

  2017cites this paper
• HYPERURICAEMIA- AN INDEPENDENT PREDICTOR OF ACUTE STROKE AND ITS OPTIMAL LEVEL TO PREVENT STROKE

  2017cites this paper
• Impact of serum uric acid, albumin and their interaction on Parkinson’s disease

  2017cites this paper
• Serum uric acid levels in patients with Parkinson’s disease: A meta-analysis

  2017cites this paper
• Targeting urate to reduce oxidative stress in Parkinson disease.

  2017cites this paper
• The Single Nucleotide Polymorphism rs1014290 of the SLC2A9 Gene Is Associated with Uric Acid Metabolism in Parkinson's Disease

  2017cites this paper
• Iron and Parkinson's disease: A systematic review and meta-analysis.

  2017cites this paper
• Urate as a Marker of Risk and Progression of Neurodegenerative Disease

  2016cites this paper
• Serum uric acid levels in Parkinson's disease and related disorders

  2016cites this paper
• "A GREAT PERTURBATION IN NATURE" : PARKINSON'S DISEASE AND SLEEP DISORDERS

  2016cites this paper
• Relationship between uric acid levels and progressive supranuclear palsy

  2016cites this paper
• Orthostatic hypotension predicts motor decline in early Parkinson disease.

  2016cites this paper
• The relation of serum uric acid levels with l-Dopa treatment and progression in patients with Parkinson’s disease

  2016cites this paper
• Dietary and Genetic Risk Factors for Parkinson's Disease

  2016cites this paper
• Association of Serum Uric Acid and Parkinson’s Disease: A Case Control Study

  2015cites this paper
• Uric Acid Promotes Osteogenic Differentiation and Inhibits Adipogenic Differentiation of Human Bone Mesenchymal Stem Cells

  2015cites this paper
• Uric Acid: A Biomarker to Predict Clinical Progression of Parkinson Disease

  2015cites this paper
• Purines in Parkinson’s: Adenosine A2A Receptors and Urate as Targets for Neuroprotection

  2015cites this paper
• DAMPs and neurodegeneration.

  2015cites this paper
• Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis.

  2015cites this paper
• EFECTO NEUROTÓXICO DEL EXTRACTO ACUOSO DE BOLDO (Peumus boldus) EN UN MODELO ANIMAL

  2014cites this paper
• Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson’s Disease in China

  2014cites this paper
• Metabolomic Analysis Provides Insights on Paraquat-Induced Parkinson-Like Symptoms in Drosophila melanogaster

  2014cites this paper
• Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

  2014cites this paper
• Inflammation and Oxidative Stress in Neurological Disorders

  2014cites this paper
• Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study

  2014cites this paper
• [Neurotoxic effect of aqueous extract of boldo (Peumus boldus) in an animal model].

  2014cites this paper
• The Role of Uric Acid as an Antioxidant in Selected Neurodegenerative Disease Pathogenesis: A Short Review

  2014cites this paper
• Gout and Parkinson's disease in older people: An observation in Taiwan

  2014cites this paper
• Contribution of Dietary Carbohydrates in Induction of Oxidative Stress

  2014cites this paper
• The Effect of Allopurinol and Inosine Administration on Xanthine Oxidoreductase Gene Expression, Mitochondrial Respiration, and Inflammation in Broiler Chickens

  2014cites this paper
• Low serum uric acid and high HDL-c levels - but not body mass index - may be related to Parkinsonâs disease

  2014cites this paper
• Gout and the risk of Parkinson’s disease in Denmark

  2013cites this paper
• Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

  2013influential citation
• Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies

  2013cites this paper
• For peer review only Low uric acid levels in patients with Parkinson's disease

  2013cites this paper
• SERUM URIC ACID LEVEL IN PATIENTS WITH PARKINSON DISEASE

  2013cites this paper
• Association of Serum Uric Acid with Parkinson Disease

  2013cites this paper
• Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50–74 years

  2013cites this paper
• Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders

  2013cites this paper
• Epidemiology and Clinical Diagnosis of Parkinson Disease.

  2013cites this paper
• Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression.

  2013cites this paper
• Mendelian Randomisation: Inferring the causal relationship between urate and associated biochemical and phenotypic parameters.

  2013cites this paper
• A Double-edged Sword: Uric Acid and Neurological Disorders

  2013cites this paper
• Serum iron and ferritin level in idiopathic Parkinson.

  2012cites this paper
• Uric acid, hyperuricemia and vascular diseases.

  2012cites this paper
• Body mass index in Parkinson's disease: a meta-analysis.

  2012cites this paper
• Lower serum UA levels in Parkinson's disease patients in the Chinese population.

  2012cites this paper
• Neuroprotection by urate on 6‐OHDA‐lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway

  2012cites this paper
• Award Number: W81XWH-11-1-0150 TITLE: Protection by Purines in Toxin Models of Parkinson's Disease PRINCIPAL INVESTIGATOR:

  2012cites this paper
• Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.

  2012cites this paper
• Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study.

  2012cites this paper
• The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study

  2012cites this paper
• Urate in Parkinson’s Disease: More Than a Biomarker?

  2012cites this paper
• Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.

  2012cites this paper
• Mitochondria and Parkinson's Disease

  2012cites this paper
• Acetyl-L-Carnitine in Parkinson’s Disease

  2012cites this paper